| Category | BioTech |
| Phone | 613-389-6565 |
| Employees | |
| Founded | 1986 |
| TOTAL | $14.2M |
| FUNDING TOTAL | $14.2M |
| Venture Round, 11/05 BioScience Managers Limited | $13M |
| Venture Round, 8/06 BioScience Managers Limited Genesys Capital | $1.18M |
Millenium Biologix Corporation operates as a biomedical company primarily in the United States and Europe. It engages in the development and commercialization of implantable medical devices and skeletal tissue regeneration products for various orthopedic uses. The company offers Skelite, a synthetic bone graft, for healing and replacement. Millenium Biologix also develops Primacoll and Peptos for the stimulation of bone tissue growth. In addition, it offers ACTES, a cell culture and tissue engineering system, which provides automated control over the biological process of tissue engineering. The company was founded in 1986 and is headquartered in Kingston, Canada.
